Spire Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
JFG
Spire Wealth Management's ARKG Position: Q2 2026 in Review
Spire Wealth Management increased its ARK Genomic Revolution ETF (ARKG) stake by 43% in Q2 2026, buying an estimated $3.5K and bringing the position to 363 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1522.
Spire Wealth Management first reported a position in ARKG in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.7M in Q1 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.
- Spire Wealth Management held 363 shares of ARK Genomic Revolution ETF worth $15.3K as of Q2 2026.
- Spire Wealth Management bought 110 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $3.5K.
- ARK Genomic Revolution ETF made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1522 holding.
- Spire Wealth Management first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 22 quarters since.
- Spire Wealth Management's ARK Genomic Revolution ETF position peaked at $1.7M in Q1 2021.
- 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.
Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.